Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma × Blood Specimen Collection × Clear all

Status

Recruiting 4 Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 46 Neoplasms 31 Colorectal Neoplasms 23 Melanoma 15 Prostatic Neoplasms 13 Neoplastic Cells, Circulating 12 Lung Neoplasms 12 Multiple Myeloma 11 Pancreatic Neoplasms 10 Ovarian Neoplasms 9 Uterine Cervical Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Colonic Neoplasms 7 Papillomavirus Infections 6 Neoplasm Metastasis 6 Lymphoma 6 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 Glioblastoma 4 Disease 4 COVID-19 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3

Interventions

Gemcitabine 26 Fluorouracil 23 Oxaliplatin 19 Cisplatin 18 Leucovorin 15 Bevacizumab 14 Paclitaxel 12 130-nm albumin-bound paclitaxel 12 Capecitabine 11 Docetaxel 10 Albumin-Bound Paclitaxel 10 Irinotecan 9 Carboplatin 9 pembrolizumab 6 Radiotherapy 6 Pemetrexed 6 Nivolumab 6 Cyclophosphamide 6 Ramucirumab 5 Erlotinib Hydrochloride 5 Trastuzumab 4 Everolimus 4 Cetuximab 4 vandetanib 3 trastuzumab deruxtecan 3 sargramostim 3 folfirinox 3 Sorafenib 3 Ipilimumab 3 Gefitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03032913 2018-04-10

PANC-CTC

University Hospital, Bordeaux

Adenocarcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡